Metagenomi Inc. Common St... (MGX)
undefined
undefined%
At close: undefined
3.32
0.15%
After-hours Dec 13, 2024, 07:52 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21
Revenue 44.76M 17.20M 243.00K
Cost of Revenue 94.40M 1.73M 387.00K
Gross Profit -49.65M 15.47M -144.00K
Operating Income -78.49M -44.64M -23.95M
Interest Income 15.47M 3.42M 43.00K
Pretax Income -60.23M -41.02M -21.44M
Net Income -68.25M -43.59M -21.44M
Selling & General & Admin 28.84M 18.70M 9.71M
Research & Development 94.40M 43.14M 14.48M
Other Expenses - 201.00K 4.00K
Operating Expenses 123.25M 61.84M 24.19M
Interest Expense - 98.00K 302.00K
Selling & Marketing Expenses - - -
Cost & Expenses 123.25M 61.84M 24.19M
Income Tax 8.03M 2.57M 306.00K
Shares Outstanding (Basic) 37.53M 29.96M 29.96M
Shares Outstanding (Diluted) 37.53M 29.96M 29.96M
EPS (Basic) -1.82 -1.45 -0.72
EPS (Diluted) -1.82 -1.45 -0.72
EBITDA -56.02M -39.19M -20.75M
Depreciation & Amortization 4.21M 1.73M 387.00K